PL3220924T3 - Lek miejscowy na uszkodzenia skóry i śluzówek związanych z epidermolisis bullosa - Google Patents

Lek miejscowy na uszkodzenia skóry i śluzówek związanych z epidermolisis bullosa

Info

Publication number
PL3220924T3
PL3220924T3 PL15860878T PL15860878T PL3220924T3 PL 3220924 T3 PL3220924 T3 PL 3220924T3 PL 15860878 T PL15860878 T PL 15860878T PL 15860878 T PL15860878 T PL 15860878T PL 3220924 T3 PL3220924 T3 PL 3220924T3
Authority
PL
Poland
Prior art keywords
skin
topical medicament
injuries associated
epidermolisis bullosa
mucosal injuries
Prior art date
Application number
PL15860878T
Other languages
English (en)
Inventor
Ramon Efrain Vasquez
Original Assignee
Rev Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rev Pharma Corp filed Critical Rev Pharma Corp
Publication of PL3220924T3 publication Critical patent/PL3220924T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A61K35/06Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/55Linaceae (Flax family), e.g. Linum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PL15860878T 2014-11-17 2015-11-13 Lek miejscowy na uszkodzenia skóry i śluzówek związanych z epidermolisis bullosa PL3220924T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462080786P 2014-11-17 2014-11-17
EP15860878.6A EP3220924B1 (en) 2014-11-17 2015-11-13 Topical medicament for skin and mucosal injuries associated with epidermolisis bullosa
PCT/US2015/060555 WO2016081296A2 (en) 2014-11-17 2015-11-13 Topical medicament for skin and mucosal injuries associated with epidermolisis bullosa

Publications (1)

Publication Number Publication Date
PL3220924T3 true PL3220924T3 (pl) 2022-02-07

Family

ID=56014668

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15860878T PL3220924T3 (pl) 2014-11-17 2015-11-13 Lek miejscowy na uszkodzenia skóry i śluzówek związanych z epidermolisis bullosa

Country Status (9)

Country Link
US (3) US10016466B2 (pl)
EP (1) EP3220924B1 (pl)
AR (1) AR102661A1 (pl)
BR (1) BR112017009963A2 (pl)
DK (1) DK3220924T3 (pl)
ES (1) ES2901419T3 (pl)
PL (1) PL3220924T3 (pl)
PT (1) PT3220924T (pl)
WO (1) WO2016081296A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3220924T3 (da) * 2014-11-17 2022-01-03 Rev Pharma Corp Lægemiddel til topisk anvendelse til hud- og slimhindeskader i forbindelse med epidermolysis bullosa
GB201504124D0 (en) 2015-03-11 2015-04-22 Proqr Therapeutics B V Oligonucleotides
CN117377461A (zh) * 2021-04-01 2024-01-09 钢铁疗法公司 含有硝苯地平和利多卡因的局部擦拭物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357923B1 (en) * 1995-10-30 2008-04-15 Cac Pharmaceuticals Topical medicament for skin injuries and disorders
US6440437B1 (en) 2000-01-24 2002-08-27 Kimberly-Clark Worldwide, Inc. Wet wipes having skin health benefits
US6673826B2 (en) * 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US8795735B1 (en) * 2007-10-01 2014-08-05 Teresa D. Carter Skin salve for treating intertrigo
US7691419B2 (en) 2007-12-20 2010-04-06 Dileva Rose Marie Compositions and methods for treating skin conditions in mammals
US9132090B2 (en) * 2009-01-13 2015-09-15 Chetan Majmudar Propofol based anesthetic with preservative
US20120308670A1 (en) * 2009-08-07 2012-12-06 Ramon Efrain Vazquez Lipi Topical Medicament for the Treatment of Psoriasis
DK3220924T3 (da) * 2014-11-17 2022-01-03 Rev Pharma Corp Lægemiddel til topisk anvendelse til hud- og slimhindeskader i forbindelse med epidermolysis bullosa

Also Published As

Publication number Publication date
WO2016081296A3 (en) 2016-12-15
ES2901419T3 (es) 2022-03-22
US20170333489A1 (en) 2017-11-23
US20180296611A1 (en) 2018-10-18
WO2016081296A2 (en) 2016-05-26
AR102661A1 (es) 2017-03-15
PT3220924T (pt) 2022-01-12
BR112017009963A2 (pt) 2018-02-14
US10016466B2 (en) 2018-07-10
US20190105357A1 (en) 2019-04-11
EP3220924B1 (en) 2021-10-20
EP3220924A4 (en) 2018-05-30
US10426803B2 (en) 2019-10-01
EP3220924A2 (en) 2017-09-27
DK3220924T3 (da) 2022-01-03
US10596205B2 (en) 2020-03-24

Similar Documents

Publication Publication Date Title
ZA201608682B (en) Boronic acid derivatives and therapeutic uses thereof
GB201403093D0 (en) Therapeutic compounds and their use
PT2991600T (pt) Micro-oclusões e métodos relacionados para o tratamento da pele
SG11201701292XA (en) Topical formulation
GB201403104D0 (en) Skin treatment device
GB201317889D0 (en) Product and use
SG11201702819YA (en) Skin cosmetic
EP2983593A4 (en) SKIN GRINDER
PL3215219T3 (pl) System do zabiegów na skórze
GB201408080D0 (en) Skin care composition
GB201616070D0 (en) Skin cosmetic
EP3131524A4 (en) Methods and compositions for topical delivery for skin care
IL248934A0 (en) Topical formulations and their uses
SG11201602573RA (en) Skin cosmetic composition
GB201408079D0 (en) Skin care composition
GB201409363D0 (en) Skin cancer treatment
GB201406172D0 (en) Therapy and pharmaceutical composition
PL3220924T3 (pl) Lek miejscowy na uszkodzenia skóry i śluzówek związanych z epidermolisis bullosa
IL245015A0 (en) Medicinal composition containing icotinib for topical treatment of the skin and its use
GB2533620B (en) Skin pricking device
GB201407091D0 (en) Hair roller
GB2527513B (en) Synthetic skin
EP3010524A4 (en) Protamine in treatment of neuronal injuries
IL251825B1 (en) Treatment of cancer and skin damage
TWM533991U (en) Skin patch